Non-implantable medical devices — diagnostic instruments, patient monitors, infusion pumps, external sensors, surgical instruments, and handheld devices — represent the largest portion of the medical device market by unit volume, and their adhesive bonding needs are substantial. These devices use epoxy to assemble housings, bond optical components, pot electronics, seal fluid pathways, and attach sensors and connectors. The biocompatibility requirements for non-implantable devices differ from implantable device requirements in ways that meaningfully change the adhesive selection criteria — understanding these differences prevents both over-specification (selecting an implant-grade adhesive with cost and complexity not needed for an external device) and under-specification (selecting an industrial adhesive that lacks the testing and documentation the device classification requires).

How Contact Nature and Duration Drive the Biocompatibility Requirement

ISO 10993-1 establishes the framework for biocompatibility evaluation by categorizing device contact into nature (surface contact, externally communicating, implant) and duration (limited under 24 hours, prolonged 24 hours to 30 days, permanent over 30 days). The applicable test battery scales with increasing contact intimacy and duration.

For a diagnostic device with no patient contact — a benchtop analyzer where samples are processed but the device housing never contacts the patient — the adhesive inside the housing requires no biocompatibility evaluation. The adhesive must meet chemical stability and performance requirements for the production and use environment, but patient protection from the adhesive chemistry is not a direct concern.

For devices with intact skin contact — a pulse oximeter probe housing bonded with epoxy, a wearable monitor attached to skin — the adhesive material used in the patient-contacting portions requires ISO 10993-5 cytotoxicity and ISO 10993-10 sensitization evaluation as a minimum for prolonged contact, adding ISO 10993-23 irritation for longer contact durations. These tests are the standard minimum battery for skin-contact medical device materials.

For devices with mucosal membrane contact — oral thermometers, respiratory masks with bonded components, otoscope specula — the mucous membrane contact category adds requirements beyond intact skin: sensitization, cytotoxicity, and irritation testing are all applicable, and depending on the specific device and duration, systemic toxicity may be added.

For devices with breached or compromised skin contact — wound dressings with adhesive bonded components, bandage-integrated sensors — the test battery increases further, requiring evaluation applicable to blood-contacting surfaces in some configurations.

Fluid-Contact vs Non-Fluid-Contact Applications

The most significant distinction within non-implantable device bonding is whether the adhesive contacts process fluids that subsequently contact the patient. Adhesive in a fluid pathway — bonding flow cell components in a blood analyzer, sealing tubing connections in an infusion pump, or assembling manifold components in a dialysis machine — leaches chemical entities into the fluid that passes through the device and reaches the patient. This extractables and leachables pathway makes the adhesive effectively an indirect patient contact material even though it is not in direct patient contact.

For fluid-contact applications, extractables testing under ISO 10993-12 (sample preparation) followed by analytical quantification and toxicological risk assessment under ISO 10993-17 is required. The extraction conditions — solvent type, temperature, extraction duration — should simulate the actual process fluid conditions. A device that processes aqueous saline at 37°C requires water extraction at 37°C; a device that contacts lipid-containing fluids requires both aqueous and non-polar extraction conditions.

Epoxy selection for fluid-contact applications prioritizes chemically stable, low-extractable formulations. Aromatic amine-cured epoxies may leach unreacted amine hardener in early service; anhydride-cured systems may leach hydrolysis products. Formulations designed for fluid-contact applications are characterized by low extractable yield under standardized conditions, and this data must be available from the adhesive supplier.

For biocompatibility data packages for fluid-contact and non-fluid-contact device bonding applications, Email Us — Incure can provide ISO 10993 test reports and extractables data for specific formulations.

Epoxy Selection Parameters Beyond Biocompatibility

Biocompatibility satisfies the patient safety requirement, but the mechanical, thermal, and chemical properties of the adhesive must also be matched to the device design requirements.

Bond strength and failure mode after sterilization are critical for devices that are reprocessed. A device housing bonded with an epoxy that is biocompatible but loses 50 percent of its bond strength after 50 autoclave cycles will fail in field use. Specifying the bond strength requirement after the maximum number of sterilization cycles the device design requires determines which formulations are actually viable for the application.

Chemical resistance to device cleaning agents is a service environment requirement that affects material selection independently of biocompatibility. Disinfection with isopropyl alcohol, quaternary ammonium compounds, sodium hypochlorite (bleach), or hydrogen peroxide is common practice for patient-contacting device surfaces. The epoxy adhesive in the device must resist degradation, swelling, or loss of adhesion when exposed to the cleaning agents specified for the device.

Optical clarity may be required for diagnostic devices with optical sensing elements. UV-cure epoxy formulations are available with high optical transmission in both UV and visible wavelengths for sensor assembly and optical window bonding in diagnostic instruments.

Electrical properties — dielectric strength, volume resistivity, and dissipation factor — are specified for epoxy used in electrical insulation applications within medical devices, particularly for devices with patient-applied electrodes or components in proximity to the patient’s body that must maintain electrical safety isolation.

Process and Documentation Requirements

Production-compatible cure schedule matters as much as the adhesive’s end-use properties. Medical device assembly lines are typically not equipped with high-temperature cure ovens, and the adhesive must cure at temperatures and times compatible with the assembly process. Two-component epoxies that cure at ambient temperature with adequate pot life for production volumes, or single-component epoxies that cure at 80°C to 120°C in short oven cycles, are the process formats most compatible with medical device manufacturing environments.

Shelf life documentation — the demonstrated usable life of the adhesive in unopened packaging under specified storage conditions — must be available for production planning and inventory management. Medical quality systems require that only materials within their documented shelf life are used in production; adhesive without a documented and verified shelf life cannot satisfy this requirement.

Contact Our Team to discuss biocompatible epoxy selection, ISO 10993 test data, extractables characterization, and production-compatible cure schedules for non-implantable medical device assembly.

Visit www.incurelab.com for more information.